Brazil · Delayed Price · Currency is BRL Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of BRL 1.17 trillion. The enterprise value is 1.23 trillion.
| Market Cap | 1.17T |
| Enterprise Value | 1.23T |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.46% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 29.49% |
| Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 13.50 and the forward PE ratio is 12.97.
| PE Ratio | 13.50 |
| Forward PE | 12.97 |
| PS Ratio | 4.44 |
| PB Ratio | 8.25 |
| P/TBV Ratio | 22.13 |
| P/FCF Ratio | 21.23 |
| P/OCF Ratio | 11.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.23, with an EV/FCF ratio of 22.25.
| EV / Earnings | 14.15 |
| EV / Sales | 4.74 |
| EV / EBITDA | 9.23 |
| EV / EBIT | 10.06 |
| EV / FCF | 22.25 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.78 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 1.53 |
| Interest Coverage | 18.58 |
Financial Efficiency
Return on equity (ROE) is 71.46% and return on invested capital (ROIC) is 41.42%.
| Return on Equity (ROE) | 71.46% |
| Return on Assets (ROA) | 20.43% |
| Return on Invested Capital (ROIC) | 41.42% |
| Return on Capital Employed (ROCE) | 53.49% |
| Revenue Per Employee | 3.36M |
| Profits Per Employee | 1.11M |
| Employee Count | 77,349 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, Novo Nordisk has paid 23.56 billion in taxes.
| Income Tax | 23.56B |
| Effective Tax Rate | 21.33% |
Stock Price Statistics
The stock price has decreased by -57.43% in the last 52 weeks. The beta is 0.35, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -57.43% |
| 50-Day Moving Average | 36.85 |
| 200-Day Moving Average | 45.82 |
| Relative Strength Index (RSI) | 43.53 |
| Average Volume (20 Days) | 35,276 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of BRL 264.23 billion and earned 86.88 billion in profits. Earnings per share was 19.54.
| Revenue | 264.23B |
| Gross Profit | 217.60B |
| Operating Income | 124.46B |
| Pretax Income | 110.44B |
| Net Income | 86.88B |
| EBITDA | 134.37B |
| EBIT | 124.46B |
| Earnings Per Share (EPS) | 19.54 |
Balance Sheet
The company has 27.28 billion in cash and 84.74 billion in debt, giving a net cash position of -57.46 billion.
| Cash & Cash Equivalents | 27.28B |
| Total Debt | 84.74B |
| Net Cash | -57.46B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 142.24B |
| Book Value Per Share | 32.01 |
| Working Capital | -43.93B |
Cash Flow
In the last 12 months, operating cash flow was 103.64 billion and capital expenditures -48.40 billion, giving a free cash flow of 55.23 billion.
| Operating Cash Flow | 103.64B |
| Capital Expenditures | -48.40B |
| Free Cash Flow | 55.23B |
| FCF Per Share | n/a |
Margins
Gross margin is 82.35%, with operating and profit margins of 47.10% and 32.88%.
| Gross Margin | 82.35% |
| Operating Margin | 47.10% |
| Pretax Margin | 41.80% |
| Profit Margin | 32.88% |
| EBITDA Margin | 50.85% |
| EBIT Margin | 47.10% |
| FCF Margin | 20.90% |
Dividends & Yields
This stock pays an annual dividend of 0.87, which amounts to a dividend yield of 2.85%.
| Dividend Per Share | 0.87 |
| Dividend Yield | 2.85% |
| Dividend Growth (YoY) | 34.48% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 49.88% |
| Buyback Yield | 0.46% |
| Shareholder Yield | 3.31% |
| Earnings Yield | 7.41% |
| FCF Yield | 4.71% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 20, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 20, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 6.13 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.13 |
| Piotroski F-Score | 4 |